InMode Ltd. (NASDAQ:INMD - Get Free Report)'s stock price crossed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $14.26 and traded as high as $15.20. InMode shares last traded at $15.03, with a volume of 799,933 shares changing hands.
Analyst Ratings Changes
Several equities analysts have recently commented on INMD shares. Weiss Ratings restated a "sell (d+)" rating on shares of InMode in a report on Thursday, August 6th. Barclays set a $19.00 price objective on InMode and gave the company an "overweight" rating in a research report on Thursday, May 7th. Finally, Robert W. Baird lowered their target price on InMode from $17.00 to $14.00 and set a "neutral" rating on the stock in a research note on Thursday, May 7th. One investment analyst has rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $16.00.
Read Our Latest Stock Report on InMode
InMode Price Performance
The stock has a market capitalization of $863.92 million, a price-to-earnings ratio of 12.22 and a beta of 1.86. The stock's 50 day simple moving average is $15.05 and its 200-day simple moving average is $14.26.
InMode (NASDAQ:INMD - Get Free Report) last announced its quarterly earnings results on Wednesday, August 5th. The healthcare company reported $0.35 EPS for the quarter, hitting the consensus estimate of $0.35. The company had revenue of $95.59 million for the quarter, compared to analyst estimates of $94.89 million. InMode had a net margin of 20.69% and a return on equity of 11.99%. InMode's quarterly revenue was up .0% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.47 EPS.
Hedge Funds Weigh In On InMode
Several hedge funds have recently bought and sold shares of INMD. Deutsche Bank AG lifted its position in shares of InMode by 35.9% in the fourth quarter. Deutsche Bank AG now owns 3,927 shares of the healthcare company's stock worth $58,000 after buying an additional 1,037 shares during the last quarter. Quadrant Capital Group LLC increased its holdings in shares of InMode by 127.8% during the 4th quarter. Quadrant Capital Group LLC now owns 1,945 shares of the healthcare company's stock valued at $29,000 after acquiring an additional 1,091 shares during the last quarter. Inspire Investing LLC increased its holdings in shares of InMode by 6.1% during the 1st quarter. Inspire Investing LLC now owns 19,366 shares of the healthcare company's stock valued at $265,000 after acquiring an additional 1,111 shares during the last quarter. Leonteq Securities AG acquired a new position in shares of InMode during the 4th quarter valued at about $26,000. Finally, Plan A Wealth LLC raised its stake in shares of InMode by 16.2% in the 4th quarter. Plan A Wealth LLC now owns 12,878 shares of the healthcare company's stock valued at $189,000 after acquiring an additional 1,793 shares in the last quarter. 68.04% of the stock is owned by institutional investors and hedge funds.
InMode Company Profile
(
Get Free Report)
InMode Ltd. NASDAQ: INMD is a medical technology company headquartered in Israel that develops, manufactures and markets devices for aesthetic and medical treatments. The company specializes in energy-based technologies, primarily radiofrequency platforms, designed to deliver minimally-invasive and non-invasive procedures.
InMode's product portfolio encompasses a range of modular systems targeting body contouring, facial rejuvenation, skin tightening and other cosmetic applications. Key offerings include devices built on proprietary radiofrequency and radiofrequency-assisted lipolysis, enabling physicians to perform treatments such as tissue coagulation, skin resurfacing and subdermal volumizing with reduced downtime.
The company distributes its technologies through direct sales operations and distribution partners, serving medical professionals across multiple geographies including North America, Europe, Asia Pacific and Latin America.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider InMode, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and InMode wasn't on the list.
While InMode currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
